Deep research on scams, frauds, and bad actors. Not financial advice, do your own DD.

Joined July 2023
Last time we reported on $NUTX, we exposed their inflated receivables. 2 months later, the company wrote down receivables by $55M. IDR reform is coming and it will have much larger impact. We estimate ~50% of revenue could disappear overnight.
4
755
Solid work. Sunlight is the best disinfectant $BZAI
1/9: We are short $BZAI (Blaize AI) because we believe that their latest $50mm deal is most likely fake, because the reported counterparty seemingly just appeared out of thin air a few months before the deal, and showcases fake products that appear to be different companies' hardware with the $BZAI and NeoTensr logo slapped on. The company is running out of money, and this PR seems to function merely as a way to boost the stock price ahead of what we believe will be a massive ATM.
2
15
4,702
Not at all surprised to see the rug pull at $HGRAF $HG.CN . Textbook pump & dump with shady cast of characters. Don't be surprised when shares are worth pennies
$HG.CN $HGRAF latest Canadian Promo - science project valued at $1b - up 10x on big promo campaign - promo spend is 6x R&D - backers include Canada’s most notorious financiers - CEO is promo queen with no op exp - CFO and CAO left in 2024 - Ind chair resigned - empty partnerships
12
1
11
7,817
$NUTX repurchased: - $5M of shares at avg price of 178 - $20M of shares in 2026 allotted another $25M to repurchase on March 4
4
2,471
We'll be publishing Part 3 on $NUTX after the holidays. Healthcare fraud and abuse is insidious. It preys on the most vulnerable and harms everyone. - Lots more to report on that hasn't been touched - We're sharing our findings with insurance cos and regulators
Replying to @CapybaraShort
Retail investors have been enamored with $NUTX's cash and receivables, what they're missing: - consolidated accounting with VIEs - subsidiaries have minority owners - 20-22% of cash and receivables don't belong to shareholders - cash and receivables are at risk of mark downs and claw backs - largest source of rev (~50%) BCBS, is furious and wants blood - employers bear most of the costs from inflated arb awards - employers directing their employees away from $NUTX - $NUTX's profitability relies on ripping off payors. Check why $NUTX peers recently failed: Adeptus Health and American Physician Partners
1
5
4,698
Retail investors have been enamored with $NUTX's cash and receivables, what they're missing: - consolidated accounting with VIEs - subsidiaries have minority owners - 20-22% of cash and receivables don't belong to shareholders - cash and receivables are at risk of mark downs and claw backs - largest source of rev (~50%) BCBS, is furious and wants blood - employers bear most of the costs from inflated arb awards - employers directing their employees away from $NUTX - $NUTX's profitability relies on ripping off payors. Check why $NUTX peers recently failed: Adeptus Health and American Physician Partners
2
1
7
10,468
BCBS of Idaho also going after $NUTX - Idaho's largest insurer - directing members away from $NUTX and to competitors - asked ID Dept of Insurance to investigate $NUTX - accuses $NUTX of egregious billing and arbitration abuse
1
1
5
1,883
$HGRAF $HG.CN down 50% from ATH another 90% to go
$HGRAF CEO & Chair has an interesting promo history. includes sex toys, animated porn, and affiliate marketing
7
2
4
45
26,802
$NUTX "Responds to Short Seller Report" Deflection and non-denial denial of allegations. CEO Vo is better suited to a prison than a board room. @nutexhealth #KnowWhatYouOwn nutexhealth.com/nutex-health…
1
8
4,888
🚨 $NUTX new report just released 🚨 Part One of our investigative report on Nutex Health. All new info, not reported elsewhere. capybararesearch.com/reports… And, stay tuned for part two. Things are spicy over at $NUTX 🌶️
10
6
9
41
39,675
$NUTX ownership is dominated by insiders and company physicians. Some didn't know $NUTX was dirty, while many others were complicit, because they traded ER ownership for $NUTX shares, and were greedy. The smart ones will sell quickly before this collapses.
1
1
5
5,299
$NUTX conflicts of interest should make longs pucker. Especially with insiders and physicians saying the CEO used these conflicts to defraud
1
7
2,841
$NUTX CEO is also accused of siphoning money out of related entities to inflate revenue and "support the share price" Some $NUTX doctors have gone along with this ruse, because they traded ownership in the ER for $NUTX shares. This will be ugly when it unwinds.
1
1
3
2,175